The in vitro antimicrobial activity of highly dispersed silica and polyhexamethylene guanidine hydrochloride composite for treating local infections
Journal Title: Клінічна фармація; Клиническая фармация - Year 2019, Vol 23, Issue 1
Abstract
Antimicrobial drug resistance (ADR) is an urgent global problem for all countries; it has a negative effect on the treatment outcome of patients. The problem can be solved by creating and introducing new antimicrobial compounds and complex drugs. Development of the combined antimicrobial agent which would show the expressed antimicrobial action and sorption properties remains relevant. Polyhexamethylenguanidine hydrochloride (PHMG-HC), being a highmolecular cationic surfactant of the guanidine group, was chosen as an antimicrobial component. Aim. To determine the antimicrobial activity of highly dispersed silica (HDS), a composite (code name CMU-211) of HDS and PHMG-HC, and PHMG-HC polymer solution. Materials and methods. 5% suspension of HDS modified by PHMG-HC polymer, 5 % suspension of HDS and 20 % aqueous solution of polyhexamethyleneguanidine hydrochloride were used in the work. The antimicrobial activity of substances was studied using test-strains of such microorganisms as Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella enterica, Klebsiella pneumoniae, and Candida albicans. Results. The composite HDS/PHMG-HC has been shown to have a high activity against C. albicans and S. aureus with the minimum inhibitory concentration (MIC) of ~10 μg/mL (calculated with reference to HDS/PHMG-HC), as well as the marked effect against E. coli (MIC of ~20 μg/mL), S. enterica (MIC of MIC ~40 μg/mL) and P. aeruginosa (MIC ~40 μg/mL). The relatively low activity of CMU-211 was reported against K. pneumoniae (MIC ~ 80 μg/mL). The activity of the composite HDS/PHMG-HC was similar to those of PHMG-HC. Conclusions. The composite HDS/PHMG-HC developed exhibits the marked antibacterial activity against gram-positive, gram-negative microorganisms, as well as C. albicans.
Authors and Affiliations
A. I. Doroshenko, O. B. Balko, Ye. P. Voronin, A. M. Doroshenko, G. V. Zaychenko
Keywords
Related Articles
- EP ID EP657695
- DOI 10.24959/cphj.19.1484
- Views 122
- Downloads 0
Дослідження субхронічної токсичності крему з наночастинками церію діоксиду при нашкірному нанесенні кролям
Актуальною є розробка фотопротекторних засобів з наночастинками церію діоксиду (НЦД) для попередження сонячних опіків та злоякісних новоутворень шкіри. Мета. Дослідити субхронічну токсичність крему з НЦД при нашкірному н...
The pharmacoeconomic analysis of the pharmacotherapy regimens for the irritable bowel syndrome using the “cost minimization” method
Irritable bowel syndrome (IBS) is a clinical pathology accompanied with a significant physical and psychological discomfort, and leading to certain economic losses. Women suffer from IBS 2.2 times more often than men. Ai...
The study of the acute toxicity in mice after administration of a phytosubstance glycosides of phenolic compounds from Vaccinum vitis-ideaea leaves in combination with arginine amino acid
At the stage of the primary pharmacological screening the determination of the toxicity class of the phytosubstances with different qualitative and quantitative composition proposed as promising products for creating pha...
Изучение эмоционально-поведенческой реакции у крыс после введения новогаленового фитокомплекса побегов Ledum palustre
При изучении новых лекарственных средств следует проводить исследования их действия на центральную нервную систему, а именно установить седативное, снотворное и анксиолитическое действие средства. Результаты исследований...
The effect of combined therapy with statins and levothyroxine on the lipid profile dynamics in patients with a comorbid course of arterial hypertension, type 2 diabetes mellitus and subclinical hypothyroidism
To date, there are no sufficiently clear recommendations for the management of patients with the TSH level between the upper limit of the control range and 10.0 mIU/L, and with a high cardiovascular risk (CVR). Aim. To a...